 | | | | Some 15,000 nurses in the state walked off the job to protest hospital understaffing that their union says has harmed patient care and exhausted health workers. | | | | | | Dutch shareholders association VEB is threatening to take Philips to court over its handling of a global recall of respiratory machines, claiming it caused billions in losses by giving incorrect information to shareholders, Dutch paper FD reported on Monday, citing a letter the VEB sent to the company. | | | | | | Nestle SA's Gerber Products Company is still in "critical task force mode" due to the U.S. infant formula shortage, its CEO Tarun Malkani said last week, adding that he expects the crunch to improve by October. | | | | | | AstraZeneca Plc on Monday won the dismissal of a U.S. shareholder lawsuit claiming that it concealed problems in developing its COVID-19 vaccine, making it unlikely the treatment would win regulatory approval in the United States. | | | | | | The European Medicines Agency (EMA) on Monday recommended a COVID-19 booster designed to combat the currently circulating Omicron BA.4/5 subvariants, days after endorsing a pair of boosters tailored to target the older BA.1 Omicron variant. | | | | | | Perrigo Co Plc said on Monday that the U.S. Food and Drug Administration has scheduled a meeting of external experts on Nov. 18 to review the application of its daily birth control pill for over-the-counter (OTC) use. | | | | | | Efforts to tackle AIDS, tuberculosis and malaria began to recover last year after being hit hard by the COVID-19 pandemic in 2020, but the world is still not on track to defeat these killer diseases, according to a report. | | | | | | The World Health Organisation expects a rise in COVID-19 in Ukraine to peak in October, possibly bringing hospitals close to their capacity threshold, WHO's director-general Tedros Adhanom Ghebreyesus said on Monday. | | | | | | The women's health clinic in Bristol, Tennessee, had a seemingly simple solution to continue providing abortions after its home state banned the procedure this summer: It moved a mile up the road to Bristol, Virginia, where abortion remained legal. | | | | | | Johnson & Johnson (J&J) has reached a A$300 million ($204.90 million) settlement in two Australian class action suits filed by Shine Lawyers for selling defective pelvic mesh implants to Australian women, the law firm said on Monday. | | | | | |
